ANGLE ORD GBP0.10
Symbol: AGL
Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.
Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.
Invest in this share within an ISA, JISA, SIPP or Investment Account
Charts
Company
Business Summary
ANGLE plc is a United Kingdom-based liquid biopsy company. The Company is engaged in the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy-non-invasive cancer diagnostics. Its platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for highly multiplexed analysis of nucleic acids and proteins. Its Parsortix PC1 Clinical system captures and harvests circulating CTCs from metastatic breast cancer patients blood for subsequent, user-validated analysis. The Parsortix PC1 Clinical System is a liquid biopsy technology. Its labs in Guildford provide specialist CTC enrichment and analysis services to support translational research studies and pharmaceutical trials. It has developed the Parsortix system, including instruments and one-time use cassettes that can be sold to third-party laboratories for their use in research, pharmaceutical development, or clinical use.
Financial Summary
BRIEF: For the six months ended 30 June 2023, ANGLE plc revenues increased from £419K to £1.2M. Net loss increased 6% to £9.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Operating costs increase of 7% to £11.4M (expense), Other Operating Income decrease from £1K (income) to £0K. Basic Earnings per Share excluding Extraordinary Items remained flat at -£0.04.
Financials
Income Statement - All values are in GBP (M).
Year Ending |
31/12/2022 |
31/12/2021 |
31/12/2020 |
31/12/2019 |
30/04/2019 |
30/04/2018 |
---|---|---|---|---|---|---|
Total Revenue | 1.04 | 1.01 | 0.76 | 0.58 | 0.68 | 0.63 |
Gross profit | 0.16 | 0.18 | 0.24 | -0.01 | 0.24 | 0.46 |
Operating Profit/Loss | -24.21 | -17.24 | -13.73 | -7.70 | -10.90 | -8.93 |
Profit Before Tax | -24.44 | -17.36 | -13.75 | -7.73 | -10.87 | -8.93 |
Profit After Tax | -21.69 | -15.01 | -11.61 | -6.25 | -8.93 | -7.54 |
Equity Holders of Parent Company | -21.69 | -15.01 | -11.61 | -6.25 | -8.94 | -7.56 |
Minority Interest | NIL | -0.66 | -0.02 | NIL | NIL | NIL |
Balance Sheet - All values are in GBP (M).
Year Ending |
31/12/2022 |
31/12/2021 |
31/12/2020 |
31/12/2019 |
30/04/2019 |
30/04/2018 |
---|---|---|---|---|---|---|
Total Non-Current Assets | 11.24 | 7.95 | 22.66 | 10.72 | 8.18 | 7.06 |
Total Current Assets | 38.63 | 39.37 | 16.39 | 23.58 | 14.84 | 11.22 |
Total Assets | 49.87 | 47.32 | 39.05 | 34.30 | 23.02 | 18.28 |
Total Liabilities | 9.81 | 7.64 | 4.71 | 3.98 | 3.68 | 1.74 |
Total Net Assets | 40.06 | 39.68 | 34.34 | 30.32 | 19.34 | 16.54 |
Shareholders Funds | 40.06 | 40.33 | 34.34 | 30.32 | 19.34 | 16.54 |
Minority Interests | NIL | -0.66 | -0.02 | NIL | NIL | NIL |
Total Equity | 40.06 | 39.68 | 34.34 | 30.32 | 19.34 | 16.54 |
Outlook
Broker View
Data shown is based on the past 75 days of broker views.
ActionBrokers |
Strong Buy1 |
Buy0 |
Neutral0 |
Sell0 |
Strong Sell0 |
---|---|---|---|---|---|
Brokers | 1 | 0 | 0 | 0 | 0 |
Consensus |
ConsensusStrong Buy |
Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.
Forecasts
Year | 2023 | 2024 | 2025 |
---|---|---|---|
Revenue | £2.08mn | £6.67mn | £15.00mn |
Pre-tax-Profit | -£20.65mn | -£13.97mn | -£11.00mn |
EPS | -£0.07p | -£0.05p | -£0.04p |
EPS Growth | 0.00% | 0.00% | 0.00% |
P/E | -1.82 | -2.8 | -999,999 |
PEG Ratio | 0.00 | 0.00 | 0.00 |
Dividend | 0.00p | 0.00p | 0.00p |
Yield | 0.00% | 0.00% | 0.00% |
Upgrades & Downgrades (Latest)
Date | Broker | Recommendation | Price | Old Target | New Target | Change |
---|---|---|---|---|---|---|
25th May 2023 | Berenberg Bank | Reiteration | 18p | 0p | 120p | Buy |
21st Apr 2023 | Berenberg Bank | Reiteration | 25p | 0p | 120p | Buy |
5th Jan 2023 | Berenberg Bank | Reiteration | 30p | 241p | 120p | Buy |
5th Aug 2022 | Berenberg Bank | Reiteration | 71p | 231p | 231p | Buy |
23rd May 2022 | Berenberg Bank | Reiteration | 99p | 0p | 195p | Buy |
13th May 2022 | Berenberg Bank | Reiteration | 103p | 0p | 195p | Buy |
28th Apr 2022 | Berenberg Bank | Reiteration | 102p | 0p | 195p | Buy |
Time & Sales
All prices are in GBX and times are in GMT. Last 20 trades shown. Trade type is estimated and should be treated as indicative only.
Date | Time | Price | Volume | Type |
---|---|---|---|---|
28 Mar 2024 | 16:22 | 12.425 | 3,810 | Sell |
28 Mar 2024 | 16:22 | 12.425 | 500 | Sell |
28 Mar 2024 | 16:18 | 12.43 | 8,046 | Sell |
28 Mar 2024 | 16:17 | 12.43 | 1,000 | Sell |
28 Mar 2024 | 15:59 | 12.98 | 500 | Buy |
28 Mar 2024 | 15:54 | 12.55 | 100,000 | Sell |
28 Mar 2024 | 15:52 | 12.51 | 372 | Sell |
28 Mar 2024 | 15:50 | 13.5 | 162,000 | Buy |
28 Mar 2024 | 15:49 | 13.35 | 162,000 | Buy |
28 Mar 2024 | 15:44 | 12.6375 | 32,166 | Sell |
28 Mar 2024 | 15:33 | 12.51 | 3,440 | Sell |
28 Mar 2024 | 14:14 | 12.6375 | 200 | Sell |
28 Mar 2024 | 14:13 | 13.175 | 10,000 | Buy |
28 Mar 2024 | 14:12 | 13.175 | 39,000 | Buy |
28 Mar 2024 | 14:09 | 12.6375 | 39,000 | Sell |
28 Mar 2024 | 13:57 | 13.1 | 7,500 | Buy |
28 Mar 2024 | 13:57 | 12.945 | 75,000 | Buy |
28 Mar 2024 | 13:49 | 12.98 | 7,500 | Buy |
28 Mar 2024 | 13:17 | 12.44 | 1,500 | Sell |
28 Mar 2024 | 12:56 | 12.443 | 20,000 | Sell |
Selected data supplied by Thomson Reuters © View restrictions.